Australian Centre for Artificial Intelligence in Medical Innovation (ACAMI)
The world’s first university innovation centre specialising in the application of artificial intelligence to accelerate the discovery and development of immunotherapies, vaccines and medical innovation
OUR KEY AREAS
The intersection of AI and medical innovation
BioNTech calls La Trobe home
La Trobe University is home to global biotechnology company BioNTech’s state-of-the-art mRNA clinical-scale manufacturing facility at the Melbourne campus in Bundoora, in an agreement facilitated by the Victorian Government. The facility will support researchers to develop investigational mRNA-based treatment options, as well as manufacture investigational candidates for clinical trials in the Asia-Pacific region.
La Trobe is already a world leader in AI and digital innovation. The Australian Centre for AI in Medical Innovation will greatly accelerate the process of translating medical breakthroughs into cost-effective and widely-accessible, personalised cancer vaccines and treatments.
The planned BioNTech facility will establish La Trobe as a centre of a new mRNA technology, providing access not only to its own researchers but also access to collaborators from across Australia and the world.
IN PARTNERSHIP
ACAMI was established through the support of the Victorian Government through mRNA Victoria.
Connect with us
News
-
Professor Richard Osborne and team joins La Trobe’s Rural Health School
A world renowned health research team led by Distinguished Professor Richard Osborne has joined La Trobe University’s Rural Health School.
-
Can sensory vests help treat anxiety in Autistic children?
La Trobe University has been awarded more than $780,000 under the Federal Government’s Medical Research Future Fund to investigate the effect of a type of sensory vest on Autistic children's mental health.
-
Scientists reveal new toxin that damages the gut
Scientists discover how a strain of bacteria destroys the gut.
Events
No upcoming events at the moment. Check back soon.